Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects

Por Härtter, Sebastian, Sennewald, Regina, Nehmiz, Gerhard, Reilly, Paul
Publicado em 2013

Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A(2) receptor and synthase inhibitor, in healthy subjects

Por Guth, Brian D, Narjes, Hans, Schubert, Hans-Dieter, Tanswell, Paul, Riedel, Axel, Nehmiz, Gerhard
Publicado em 2004

Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin

Por Härtter, Sebastian, Koenen-Bergmann, Michael, Sharma, Ashish, Nehmiz, Gerhard, Lemke, Ute, Timmer, Wolfgang, Reilly, Paul A
Publicado em 2012

Response to the letter by Dr Chin and co-workers

Por Härtter, Sebastian, Koenen-Bergmann, Michael, Sharma, Ashish, Nehmiz, Gerhard, Lemke, Ute, Timmer, Wolfgang, Reilly, Paul A
Publicado em 2013

Antiviral Effect, Safety, and Pharmacokinetics of Five-Day Oral Administration of Deleobuvir (BI 207127), an Investigational Hepatitis C Virus RNA Polymerase Inhibitor, in Patients...

Por Larrey, Dominique, Lohse, Ansgar W., Trepo, Christian, Bronowicki, Jean-Pierre, Arastéh, Keikawus, Bourlière, Marc, Calleja, Jose Luis, Stern, Jerry O., Nehmiz, Gerhard, Abdallah, Nasri, Berger, Kristi L., Marquis, Martin, Steffgen, Jürgen, Kukolj, George
Publicado em 2013